Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.
Pragma Bio's investors include Plug and Play, Viking Global Investors, Merck Global Health Innovation Fund, The Venture Collective, Iaso Ventures.
Pragma Bio is headquartered in Millbrae, United States.
Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.
Pragma Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pragma Bio — Funding & Investors." VCBacked, July 31, 2023, https://www.vcbacked.co/company/pragma-bio. Accessed September 14, 2026.
VCBacked. (2023). Pragma Bio — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/pragma-bio
{{cite web |title=Pragma Bio — Funding & Investors |url=https://www.vcbacked.co/company/pragma-bio |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated